Wed, September 20, 2023
Tue, September 19, 2023
Mon, September 18, 2023

Shawn Egan Initiated (ARWR) at Hold and Held Target at $33 on, Sep 19th, 2023

Shawn Egan of Citigroup, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold and Held Target at $33 on, Sep 19th, 2023.

Shawn has made no other calls on ARWR in the last 4 months.



There are 7 other peers that have a rating on ARWR. Out of the 7 peers that are also analyzing ARWR, 0 agree with Shawn's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Shawn


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Wednesday, August 9th, 2023
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $47 on, Tuesday, August 8th, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $60 on, Tuesday, August 8th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $60 on, Tuesday, August 8th, 2023
  • Brendan Smith of "TD Cowen" Initiated at Buy on, Friday, July 21st, 2023
  • Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $55 on, Thursday, July 20th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $59 on, Friday, June 2nd, 2023